Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Benchmarking of DDA and plexDIA analysis with SILAC-labelled Hela cell samples

ABSTRACT: SILAC labelled Hela cell lysates were mixed in defined ratios and analysed using both DDA and DIA methods, to serve as a benchmark for the novel plexDIA features of DIA-NN.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Hela Cell

DISEASE(S): Cervix Carcinoma

SUBMITTER: Toman Bortecen

LAB HEAD: Jeroen Krijgsveld

PROVIDER: PXD039580 | Pride | 2023-10-19

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20220603_QE1_TB_A3R1_DDA1.raw	Raw
	20220603_QE1_TB_A3R1_DDA2.raw	Raw
	20220603_QE1_TB_A3R1_DDA3.raw	Raw
	20220603_QE1_TB_A3R2_DDA1.raw	Raw
	20220603_QE1_TB_A3R2_DDA2.raw	Raw

Items per page:

1 - 5 of 12

Similar Datasets

Benchmarking plexDIA analysis with SILAC-labelled Hela cell samples

Project description:SILAC labelled Hela cell lysates were mixed in defined ratios and analysed using both DDA and DIA methods, to serve as a benchmark for the novel plexDIA features of DIA-NN.

2023-10-19 | PXD039578 | Pride

Proteomic analysis of GC7-treated senescent and proliferating BJ fibroblasts

Project description:Quantitative analysis of global proteomic changes in proliferating and senescent BJ fibroblasts, treated with eIF5A hypusination inhibitor GC7 (10 uM) for 12h.

2024-07-12 | PXD034251 | Pride

semi-automated enrichment of AHA-containing newly-synthesized proteins with magnetic alkyne agarose beads

Project description:Development of an improved workflow for newly synthesized proteome analysis, based on combined pulsed metabolic labelling with L-azidohomoalanine (AHA) and semi-automated click chemistry-based enrichments with magnetic alkyne agarose beads.

2023-10-19 | PXD036886 | Pride

Nascent proteome analysis of proliferating and senescent BJ fibroblast treated with GC7

Project description:Analysis of proteomic changes in proliferating and senescent BJ fibroblast treated with eIF5A hypusination inhibitor GC7 for 12h.

2024-07-12 | PXD034334 | Pride

Applying plexDIA analysis to newly synthesized proteome samples generated using a semi-automated enrichment protocol

Project description:Samples generated with a newly development semi-automated enrichment protocol for newly synthesized proteins, using different amounts of protein input, were analysed using data-independent acquisition (DIA) and processed with the plexDIA software features of DIA-NN (https://www.nature.com/articles/s41587-022-01389-w).

2023-10-19 | PXD043817 | Pride

Newly synthesized proteome analysis of interferon gamma treated Hela cells

Project description:Using a newly-developed workflow for quantitative newly synthesized proteome analysis (QuaNPA), featuring automated sample processing and multiplexed DIA (plexDIA) analysis, changes in the newly synthesized proteome of IFN-gamma treated Hela cells were monitored over time.

2023-10-19 | PXD038915 | Pride

Newly synthesized proteome analysis of EPP2 cells, with combinations of induced Ctu1- or Elp3 KO and DMSO-, Torin1- and Rapamycin treatments

Project description:Newly synthesized proteome analysis of EPP2 murine pancreatic cancer cells with induced knockout of tRNA wobble enzymes Elp3 or Ctu1 and mTOR inhibitor treatment. Knockouts were induced for 4 days, mTOR inhibitors were 5 h rapamycin [50 nM] or torin 1 [50 nM].

2025-05-07 | PXD047316 | Pride

The jumbo phage killer immune system targets early infection of nucleus-forming jumbo phages

Project description:We profiled the proteomics of jumbophage phiKZ infected Pseudomonas aerugionsaÂ cells to understand the effect of a newly discovered bacterial immune system (named jumbophage killer or Juk) on phiKZ early infection. Specifically, Juk+ and Juk- P. aeruginosa cells were infected with phiKZ at MOI 2.5. Infected cells were collected at five minutes post-infection and prepared for proteomics analysis.Â

2025-06-16 | PXD052338 | Pride

nascent proteome analysis of HCT116 TP53 wild type and TP53 knockout cells treated with Neocarcinostatin (NCS) for 6h

Project description:In order to investigate the potential role of TP53 in regulating translation, HCT116 wild type and TP53 knockout cells were analyzed using both RNA sequencing, Ribosome sequencing and nascent proteome analysis. The cells were treated with 0.2 µg/ml Neocarcinostatin (NCS) to induce DNA damage and activate TP53.

2022-04-27 | PXD029512 | Pride